Lewis Base Organocatalyzed Enantioselective Hydrosilylation of 1,4-Benzoxazines

Yan Jiang; Li-Xin Liu; Wei-Cheng Yuan; Xiao-Mei Zhang

doi:10.1055/s-0031-1290405

Synlett, Table of Contents

Synlett 2012; 23(12): 1797-1800
DOI: 10.1055/s-0031-1290405

letter

Lewis Base Organocatalyzed Enantioselective Hydrosilylation of 1,4-Benzoxazines

Authors

Yan Jiang

^aKey Laboratory for Asymmetric Synthesis & Chirotechnology of Sichuan Province, Chengdu Institute of Organic Chemistry, Chinese Academy of Sciences, Chengdu 610041, P. R. of China

^bGraduate School of Chinese Academy of Sciences, Beijing 100049, P. R. of China, Fax: +86(28)85257883 Email: xmzhang@cioc.ac.cn
Li-Xin Liu

^aKey Laboratory for Asymmetric Synthesis & Chirotechnology of Sichuan Province, Chengdu Institute of Organic Chemistry, Chinese Academy of Sciences, Chengdu 610041, P. R. of China

^bGraduate School of Chinese Academy of Sciences, Beijing 100049, P. R. of China, Fax: +86(28)85257883 Email: xmzhang@cioc.ac.cn
Wei-Cheng Yuan

^aKey Laboratory for Asymmetric Synthesis & Chirotechnology of Sichuan Province, Chengdu Institute of Organic Chemistry, Chinese Academy of Sciences, Chengdu 610041, P. R. of China
Xiao-Mei Zhang*

^aKey Laboratory for Asymmetric Synthesis & Chirotechnology of Sichuan Province, Chengdu Institute of Organic Chemistry, Chinese Academy of Sciences, Chengdu 610041, P. R. of China

Abstract

All articles of this category

Abstract

A chiral Lewis base organocatalyzed enantioselective hydrosilylation of 1,4-benzoxazines is presented. The reactions afforded various enantioenriched 3-substituted dihydro-2H-1,4-benzoxazines with high yields (up to 98%) in moderate enantioselectivities (up to 87% ee).

Key words

asymmetric catalysis - enantioselectivity - heterocycles - hydrosilylation - imines

Full Text

References

References and Notes

For selected examples, see:

1a Brown KS, Djerassi C. J. Am. Chem. Soc. 1964; 86: 2451
1b Hayakawa I, Atarashi S, Yokohama S, Imamura M, Sakano K, Furukawa M. Antimicrob. Agents Chemother. 1985; 29: 163
1c Bouzard D In Antibiotics and Antiviral Compounds . Korhn K, Rirst HA, Maag H. VCH; Weinheim: 1993
1d Belattar A, Saxton JE. J. Chem. Soc., Perkin Trans. 1 1992; 679
1e Daiichi S. Drugs Future 1992; 17: 559
1f Shim JY, Collantes ER, Welsh WJ. J. Med. Chem. 1998; 41: 4521
1g McAllister SD, Rizvi G, Anavi-Goffer S, Hurst DP, Barnett-Norris J, Lynch DL, Reggio PH, Abood ME. J. Med. Chem. 2003; 46: 5139
1h Achari B, Mandal SB, Dutta PK, Chowdhury C. Synlett 2004; 2449
1i Jiao PF, Zhao BX, Wang WW, Shin DS, He QX, Wan MS, Shin DS, Miao JY. Bioorg. Med. Chem. Lett. 2006; 16: 2862

2a Largeron M, Lockhart B, Pfeiffer B, Fleury MB. J. Med. Chem. 1999; 42: 5043
2b Mayer S, Arrault A, Guillaumet G, Merour JY. J. Heterocycl. Chem. 2001; 38: 221
2c Majumdar KC, Ray K, Ponra S. Tetrahedron Lett. 2010; 51: 5437
2d Ciske FL, Barbachyn MR, Genin MJ, Grega KC, Lee CS, Dolak LA, Seest EP, Watt W, Adams WJ, Friis JM, Ford CW, Zurenko GE. Bioorg. Med. Chem. Lett. 2003; 13: 4235

3a Fujiwara T, Tsurumi H, Sato YT. EP 0304684, 1989
3b Hayakawa J, Atarashi S, Yokohama S, Imamura M, Higashihashi N, Oshima M. EP 0206283, 1986
3c Charushin VN, Krasnov VP, Levit GL, Korolyova MA, Kodess MI, Chupakhin ON, Kim MH, Lee HS, Park YJ, Kim KC. Tetrahedron: Asymmetry 1999; 10: 2691
3d Miyadera A, Imura A. Tetrahedron: Asymmetry 1999; 10: 119
3e Krasnov VP, Levit GL, Bukrina IM, Andreeva IN, Sadretdinova LS, Korolyova MA, Kodess MI, Charushin VN, Chupakhin ON. Tetrahedron: Asymmetry 2003; 14: 1985
3f Krasnov VP, Levit GL, Kodess MI, Charushin VN, Chupakhin ON. Tetrahedron: Asymmetry 2004; 15: 859
3g Potemkin VA, Krasnov VP, Levit GL, Bartashevich EV, Andreeva IN, Kuzminsky MB, Anikin NA, Charushin VN, Chupakhin ON. Mendeleev Commun. 2004; 14: 69

4a Atarashi S, Tsurumi H, Fujiwara T, Hayakawa I. J. Heterocycl. Chem. 1991; 28: 329
4b Kang SB, Ahn EJ, Kim Y. Tetrahedron Lett. 1996; 37: 9317
4c Xie LJ. Chin. Chem. Lett. 1995; 6: 857
4d Adrio J, Carretero JC, Ruano JL. G, Pallarés A, Vicioso M. Heterocycles 1999; 51: 1563
4e Sakano K, Yokohama S, Hayakawa I, Atarashi S, Kadoya S. Agric. Biol. Chem. 1987; 51: 1265
4f Imamura M, Hayakawa I. Chem. Pharm. Bull. 1987; 35: 1896

5a Satoh K, Inenaga M, Kanai K. Tetrahedron: Asymmetry 1998; 9: 2657
5b Zhou YG, Yang PY, Han XW. J. Org. Chem. 2005; 70: 1679
5c Rueping M, Antonchick AP, Theissmann T. Angew. Chem. Int. Ed. 2006; 45: 6751
5d Rueping M, Sugiono E, Steck A, Theissmann T. Adv. Synth. Catal. 2010; 352: 281
5e Chen QA, Gao K, Duan Y, Ye ZS, Shi L, Yang Y, Zhou YG. J. Am. Chem. Soc. 2012; 134: 2442
5f Malkov AV, Vranková K, Stoncius S, Kočovský P. J. Org. Chem. 2009; 74: 5839

For reviews on Lewis base activation of Lewis acids, see:

6a Rendler S, Oestreich M. Synthesis 2005; 1727
6b Orito Y, Nakajima M. Synthesis 2006; 1391
6c Denmark SE, Beutner GL. Angew. Chem. Int. Ed. 2008; 47: 1560 ; Angew. Chem. 2008, 120, 1584

For reviews, see:

7a Kočovský P, Malkov AV. Chiral Lewis Bases as Catalysts . In Enantioselective Organocatalysis . Dalko PI. Wiley-VCH; Weinheim: 2007. 255
7b Kagan HB. Organocatalytic Enantioselective Reduction of Olefins, Ketones and Imines. In Enantioselective Organocatalysis. Dalko PI. Wiley-VCH; Weinheim: 2007. 391
7c Guizzetti S, Benaglia M. Eur. J. Org. Chem. 2010; 5529
7d Weickgenannt A, Oestreich M. ChemCatChem 2011; 3: 1527

For representative examples, see:

8a Malkov AV, Stončius S, Vranková K, Arndt M, Kočovský P. Chem.–Eur. J. 2008; 14: 8082
8b Malkov AV, Stončius S, Kočovský P. Angew. Chem. Int. Ed. 2007; 46: 3722
8c Malkov AV, Liddon AJ. P. S, Ramirez-Lopez P, Bendova L, Haigh D, Kočovský P. Angew. Chem. Int. Ed. 2006; 45: 1432
8d Xiao YC, Wang C, Yao Y, Sun J, Chen YC. Angew. Chem. Int. Ed. 2011; 50: 10661
8e Wu XJ, Li Y, Wang C, Zhou L, Lu XX, Sun J. Chem.–Eur. J. 2011; 17: 2846
8f Pei D, Zhang Y, Wei SY, Wang M, Sun J. Adv. Synth. Catal. 2008; 350: 619
8g Zhou L, Wang Z, Wei S, Sun J. Chem. Commun. 2007; 2977
8h Pei D, Wang ZY, Wei SY, Zhang Y, Sun J. Org. Lett. 2006; 8: 5913
8i Onomura O, Kouchi Y, Iwasaki F, Matsumura Y. Tetrahedron Lett. 2006; 47: 3751
8j Guizzetti S, Benaglia M, Bonsignore M, Raimondi L. Org. Biomol. Chem. 2011; 9: 739
8k Guizzetti S, Benaglia M, Rossi S. Org. Lett. 2009; 11: 2928
8l Sugiura M, Kumahara M, Nakajima M. Chem. Commun. 2009; 3585
8m Xue ZY, Liu LX, Jiang Y, Yuan WC, Zhang XM. Eur. J. Org. Chem. 2012; 251
8n Jiang Y, Chen X, Zheng YS, Xue ZY, Shu C, Yuan WC, Zhang XM. Angew. Chem. Int. Ed. 2011; 50: 7304
8o Chen X, Zheng YS, Shu C, Yuan WC, Liu B, Zhang XM. J. Org. Chem. 2011; 76: 9109
8p Zheng HJ, Chen WB, Wu ZJ, Deng JG, Lin WQ, Yuan WC, Zhang XM. Chem.–Eur. J. 2008; 14: 9864
8q Xue ZY, Jiang Y, Peng XZ, Yuan WC, Zhang XM. Adv. Synth. Catal. 2010; 352: 2132
8r Xue ZY, Jiang Y, Yuan WC, Zhang XM. Eur. J. Org. Chem. 2010; 616
8s Zheng HJ, Deng JG, Lin WQ, Zhang XM. Tetrahedron Lett. 2007; 48: 7934

9 Enantioselective Hydrosilylation of Benzoxazine; General Procedure: Trichlorosilane (51 μL, 0.5 mmol, 2.0 equiv) dissolved in THF (0.15 mL) was added to a stirred solution of 1,4-benzoxazine 2 (0.25 mmol) and catalyst (0.025 mmol) in anhydrous THF (2 mL) at 0 °C. The mixture was stirred at the same temperature for 12 h, then quenched with sat. aq NaHCO₃ and extracted with EtOAc. The combined extract was washed with brine and dried over anhydrous Na₂SO₄ and the solvents were evaporated. Purification by column chromatography (silica gel; hexane–EtOAc) afforded pure product 3. The ee values were determined by using established HPLC techniques with chiral stationary phases
10 3-(Furan-2-yl)-3,4-dihydro-2H-benzo[b][1,4]oxazine (3l): Yield: 90%; light-yellow oil; 87% ee. ¹H NMR (300 MHz, CDCl₃): δ = 7.39 (d, J = 0.9 Hz, 1 H), 6.84–6.78 (m, 2 H), 6.72–6.65 (m, 2 H), 6.36 (dd, J = 1.8, 3.2 Hz, 1 H), 6.30 (d, J = 3.2 Hz, 1 H), 4.63–4.62 (m, 1 H), 4.43–4.38 (m, 1 H), 4.23 (dd, J = 7.0, 10.6 Hz, 1 H), 4.10 (br s, 1 H). ¹³C NMR (75 MHz, CDCl₃): δ = 152.5, 143.4, 142.2, 132.6, 121.5, 119.2, 116.6, 115.6, 110.4, 106.7, 67.8, 48.3. HPLC (OD-H column; n-hexane–2-propanol, 80:20; flow rate = 1.0 mL/min): t _R = 8.08 (minor), 9.12 (major) min; [α]_D ²⁰ +32.6 (c = 0.4, CHCl₃). HRMS (ESI): m/z [M + H]⁺ calcd. for C₁₂H₁₁NO₂ + H⁺: 202.0863; found: 202.0865

Supplementary Material

Supporting Information (PDF) (opens in new window)